1. Home
  2. QUIK vs CDXS Comparison

QUIK vs CDXS Comparison

Compare QUIK & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$12.50

Market Cap

139.5M

Sector

Technology

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$2.51

Market Cap

141.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
CDXS
Founded
1988
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Major Chemicals
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
139.5M
141.8M
IPO Year
1997
2008

Fundamental Metrics

Financial Performance
Metric
QUIK
CDXS
Price
$12.50
$2.51
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
180.5K
1.4M
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.82
EPS
N/A
N/A
Revenue
$20,112,000.00
$138,590,000.00
Revenue This Year
$75.17
$7.73
Revenue Next Year
$16.04
$14.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.30
52 Week Low
$4.34
$0.96
52 Week High
$12.36
$3.87

Technical Indicators

Market Signals
Indicator
QUIK
CDXS
Relative Strength Index (RSI) 78.14 75.03
Support Level $5.58 $2.37
Resistance Level N/A $2.56
Average True Range (ATR) 0.63 0.17
MACD 0.21 0.05
Stochastic Oscillator 89.35 92.06

Price Performance

Historical Comparison
QUIK
CDXS

About QUIK QuickLogic Corporation

QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: